Hypercholesterolemia.
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group will be prescribed a 40 gram capsule of fenugreek hydrolyzed protein daily for 2 months. Lipid profile, hs-CRP level, fasting blood sugar, bl
Sponsors
National institute for medical research development
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with low to moderate risk for cardiovascular events LDL 116 -180 mg /dL
Exclusion criteria
Exclusion criteria: Drinking alcohol, Use of effective supplements on blood lipids (such as fish oil), Immunosuppressive drugs, blood lipid-lowering drugs (statins, fibrates, niacin, …) People with hypothyroidism, nephrotic syndrome or renal dysfunction or liver dysfunction People with uncontrolled hypertension (systolic blood pressure greater than 160 or diastolic blood pressure greater than 100 mmHg), History of dizziness and convulsions, Pregnancy or lactation Sensitivity to studied plant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean of Total Cholesterol. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of High-Density Lipoprotein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of Low-Density Lipoprotein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of Triglyceride. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of high-sensitivity C-reactive protein. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean of fasting blood sugar. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood level mg mg / dL by laboratory.;Mean of blood pressure. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Blood pressure monitor.;Mean of body mass index. Timepoint: Before the intervention and 2 months after the intervention. Method of measurement: Tape meters, digital scales and calculation formulas. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Badiee Gavarti
Esfahan University of Medical Sciences
Outcome results
None listed